Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2026 Sep 28;16:2000045. doi: 10.3389/fonc.2026.2000045

Correction: Transplant or dialysis: what’s the better choice for RCC-induced ESRD patients? A 20-year analysis of OPTN/UNOS data

Xiaowei Hao 1,2,†,#, Wenhui Lai 1,3,†,#, Xinze Xia 1,4, Junnan Xu 1, Yangyang Wu 1, Chao Lv 1, Kaikai Lv 1, Shuai Huang 1,3, Zhenjun Luo 1,5, Qingyang Meng 1, Qing Yuan 1,*, Jun Dong 1,*
PMCID: PMC13655917  PMID: 42865887

Affiliation 2, “Department of Urology, No.971 Hospital of PLA Navy, Tsingtao, Shandong, China,” was omitted from the paper. This affiliation has now been added for author “Xiaowei Hao”.

The original version of this article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES